Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

SELL
$40.25 - $52.99 $84,927 - $111,808
-2,110 Reduced 15.61%
11,411 $473,000
Q1 2024

Apr 19, 2024

BUY
$47.98 - $54.4 $115,104 - $130,505
2,399 Added 21.57%
13,521 $733,000
Q4 2023

Jan 19, 2024

SELL
$48.48 - $57.85 $220,147 - $262,696
-4,541 Reduced 28.99%
11,122 $570,000
Q3 2023

Oct 20, 2023

SELL
$57.89 - $64.73 $61,768 - $69,066
-1,067 Reduced 6.38%
15,663 $909,000
Q2 2023

Aug 09, 2023

SELL
$63.71 - $70.74 $42,112 - $46,759
-661 Reduced 3.8%
16,730 $1.07 Million
Q1 2023

May 05, 2023

SELL
$65.71 - $74.53 $91,665 - $103,969
-1,395 Reduced 7.43%
17,391 $1.21 Million
Q4 2022

Feb 10, 2023

SELL
$68.48 - $81.09 $11,230 - $13,298
-164 Reduced 0.87%
18,786 $1.35 Million
Q3 2022

Oct 27, 2022

SELL
$0.13 - $76.84 $36 - $21,361
-278 Reduced 1.45%
18,950 $1.35 Million
Q2 2022

Aug 09, 2022

SELL
$72.62 - $79.98 $7,479 - $8,237
-103 Reduced 0.53%
19,228 $1.48 Million
Q1 2022

Apr 13, 2022

SELL
$61.48 - $73.72 $40,330 - $48,360
-656 Reduced 3.28%
19,331 $1.41 Million
Q4 2021

Jan 18, 2022

BUY
$53.63 - $62.52 $47,355 - $55,205
883 Added 4.62%
19,987 $1.25 Million
Q3 2021

Oct 18, 2021

BUY
$59.17 - $69.31 $15,739 - $18,436
266 Added 1.41%
19,104 $1.13 Million
Q2 2021

Jul 15, 2021

SELL
$61.91 - $67.42 $25,754 - $28,046
-416 Reduced 2.16%
18,838 $1.26 Million
Q1 2021

Apr 12, 2021

BUY
$59.34 - $66.74 $283,229 - $318,550
4,773 Added 32.96%
19,254 $1.22 Million
Q4 2020

Jan 13, 2021

SELL
$57.74 - $65.43 $87,302 - $98,930
-1,512 Reduced 9.45%
14,481 $898,000
Q3 2020

Oct 23, 2020

SELL
$57.43 - $63.64 $424,407 - $470,299
-7,390 Reduced 31.6%
15,993 $964,000
Q2 2020

Jul 16, 2020

BUY
$54.82 - $64.09 $109,859 - $128,436
2,004 Added 9.37%
23,383 $1.38 Million
Q1 2020

Apr 23, 2020

SELL
$46.4 - $67.43 $303,734 - $441,396
-6,546 Reduced 23.44%
21,379 $1.19 Million
Q4 2019

Feb 05, 2020

BUY
$49.21 - $64.19 $270,310 - $352,595
5,493 Added 24.49%
27,925 $1.59 Million
Q3 2019

Oct 18, 2019

BUY
$42.77 - $50.71 $122,536 - $145,284
2,865 Added 14.64%
22,432 $1.14 Million
Q2 2019

Aug 01, 2019

BUY
$44.62 - $49.34 $539,634 - $596,717
12,094 Added 161.84%
19,567 $894,000
Q1 2019

May 15, 2019

BUY
$45.12 - $53.8 $337,181 - $402,047
7,473 New
7,473 $356,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Coastal Investment Advisors, Inc. Portfolio

Follow Coastal Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coastal Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Coastal Investment Advisors, Inc. with notifications on news.